EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study

Jaclyn N Roland-McGowan, Oscar M Ose, Yun Yu, Emile Latour, Elizabeth Berry, Sancy A Leachman, Bryan T Carroll, Wesley Y Yu

Journal of the American Academy of Dermatology · 2026-06 · 94 (6) · 1697-1704

DOI: 10.1016/j.jaad.2026.02.010 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026-06. Verfasst von Jaclyn N Roland-McGowan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Oregon Health & Science University, Portland, Oregon; Department of Dermatology, Oregon Health & Science University, Portland, Or…. Hauptthemen laut MEDLINE: Dysplastic Nevus Syndrome, Decision Support Techniques, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: NCATS NIH HHS, VA Career Development Award, Melanoma Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patient decision aids (PDAs) support shared decision-making by presenting treatment options clearly and objectively. However, little is known about how risk framing and diagnostic severity labels influence patient preferences in dermatology. OBJECTIVE: Assess how PDA format (quantitative vs qualitative) and dysplastic nevus severity (mild, moderate, or severe) affect understanding, risk perception, confidence, and treatment intent. METHODS: In this randomized A/B testing design, 600 US adults viewed a quantitative or qualitative PDA describing a mild, moderate, or severe dysplastic nevus scenario. Self-reported outcomes included understanding, treatment selection (excision vs monitoring), satisfaction, decision-making confidence, perceived melanoma risk, and concern. Analyses used nonparametric tests and logistic regression. RESULTS: Quantitative PDAs improved self-reported understanding (median 80 vs 72; P = .008) and confidence (P = .003) and lowered perceived melanoma risk for monitoring (P = .003) and excision (P < .001), but did not change excision intent (52% vs 53%; odds ratio 1.04, 95% CI 0.75-1.43; P = .818). Dysplastic nevus severity significantly increased excision intent (31% mild, 41% moderate, 72% severe; P < .001), without affecting understanding. CONCLUSION: Quantitative PDAs enhance comprehension, yet diagnostic severity labels predominantly drive treatment intent. Approximately one-third of participants diverged from expert recommendations despite high comprehension, underscoring that individual values drive treatment choices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dysplastic Nevus SyndromeDecision Support TechniquesSkin NeoplasmsHumansFemaleMaleAdultMiddle AgedRisk AssessmentSeverity of Illness IndexMelanomaYoung AdultPatient PreferenceAged

Stichwörter der Autor:innen

atypical nevicomprehensiondysplastic neviframing effectmelanoma riskpatient decision aidsrisk communicationrisk perceptionshared decision-making

Autor:innen und Institutionen

  • School of Medicine, Oregon Health & Science University, Portland, Oregon; Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
  • School of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
  • Department of Dermatology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio.
  • Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Operative Care Division, VA Portland Medical Center, Portland, Oregon. Electronic address: yuwe@ohsu.edu.

Förderung

  • NCATS NIH HHS
  • VA Career Development Award
  • Melanoma Research Foundation
  • National Institutes of Health
  • Kuni Foundation
  • Dermatology Foundation
  • National Center for Advancing Translational Sciences
  • U.S. Department of Defense

Zitieren

APA

Roland-McGowan, J. N., Ose, O. M., Yu, Y., Latour, E., Berry, E., Leachman, S. A., Carroll, B. T., & Yu, W. Y. (2026). Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study. Journal of the American Academy of Dermatology, 94(6), 1697-1704. https://doi.org/10.1016/j.jaad.2026.02.010

Vancouver

Roland-McGowan JN, Ose OM, Yu Y, Latour E, Berry E, Leachman SA, et al. Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study. Journal of the American Academy of Dermatology. 2026;94(6):1697-1704. doi:10.1016/j.jaad.2026.02.010

BibTeX
@article{RolandMcGowan2026,
  author = {Roland-McGowan, Jaclyn N and Ose, Oscar M and Yu, Yun and Latour, Emile and Berry, Elizabeth and Leachman, Sancy A and Carroll, Bryan T and Yu, Wesley Y},
  title = {Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {94},
  number = {6},
  pages = {1697--1704},
  doi = {10.1016/j.jaad.2026.02.010}
}
Kostenlos starten →